CBX8 and CD96 Are Important Prognostic Biomarkers of Colorectal Cancer

Background Colorectal cancer (CRC) is one of the most common malignancies worldwide, with high morbidity and mortality rates. The purpose of this study was to identify potential biomarkers in the progression of CRC. Material/Methods Gene and isoform expression datasets of CRC was downloaded from The Cancer Genome Atlas (TCGA). EBSeq of R was used for the normalization of gene and isoform expression, as well as the identification of differential expression genes (DEGs) and isoforms (DEIs) of CRC samples compared with normal samples. The enriched functions of DEGs and DEIs were obtained based on the Database for Annotation, Visualization and Integrated Discovery (DAVID). An independent dataset, GSE38832, was downloaded from the Gene Expression Omnibus (GEO) database for survival analysis of genes with sustained decreased/increased expression values at both gene and isoform levels with the development of CRC. Results A total of 2301 genes and 4241 isoforms were found to be significantly differentially expressed in stage I–IV CRC samples. They are closely associated with muscle or cell system activity. Sixteen genes were screened out with sustained decreased/increased expression values at both gene and isoform levels with the development of CRC. Aberrant CBX8 and CD96 expressions were found to be significantly associated with CRC survival. Conclusions Through combined analysis of gene and isoform expression profiles, we identified several potential biomarkers that may play an important role in the development of CRC and could be helpful in its early diagnosis and treatment.

[1]  M. Yano,et al.  Clinicopathological characteristics and prognosis of stage IV colorectal cancer. , 2015, Molecular and clinical oncology.

[2]  Y. Sang,et al.  Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer , 2014, Oncotarget.

[3]  K. Ghias,et al.  Colorectal cancer carcinogenesis: a review of mechanisms , 2016, Cancer biology & medicine.

[4]  Rui Chen,et al.  FAS rs2234767 and rs1800682 polymorphisms jointly contributed to risk of colorectal cancer by affecting SP1/STAT1 complex recruitment to chromatin , 2016, Scientific Reports.

[5]  R. Majeti.  Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells , 2011, Oncogene.

[6]  L. Klampfer,et al.  Prognostic and Predictive Significance of Stromal Fibroblasts and Macrophages in Colon Cancer , 2015, Biomarkers in cancer.

[7]  P. Hokland,et al.  Nonviral transfection of leukemic primary cells and cells lines by siRNA-a direct comparison between Nucleofection and Accell delivery. , 2011, Experimental hematology.

[8]  R. Loffeld,et al.  Impact of age and comorbidity on survival in colorectal cancer. , 2015, Journal of gastrointestinal oncology.

[9]  X. Chen,et al.  Molecular and Cellular Pathobiology Nuclear Factor of Activated T-cell Activity Is Associated with Metastatic Capacity in Colon Cancer , 2014 .

[10]  May D. Wang,et al.  Comparison of RNA-seq and microarray-based models for clinical endpoint prediction , 2015, Genome Biology.

[11]  R. Lothe,et al.  Novel RNA variants in colorectal cancers , 2015, Oncotarget.

[12]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[13]  G. Otterson,et al.  Overexpression of Rad51C splice variants in colorectal tumors , 2014, Oncotarget.

[14]  I. López,et al.  The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties. , 2015, Cancer letters.

[15]  M. Huycke,et al.  Colorectal cancer: role of commensal bacteria and bystander effects , 2015, Gut microbes.

[16]  H. Mayani,et al.  Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia. , 2014, Archives of medical research.

[17]  Helen E. Lockstone,et al.  Exon array data analysis using Affymetrix power tools and R statistical software , 2011, Briefings Bioinform..

[18]  J. Hubbard.  Management of Colorectal Cancer in Older Adults. , 2016, Clinics in geriatric medicine.

[19]  Gerhard Jakse,et al.  The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. , 2009, European urology.

[20]  F. Xing,et al.  CBX8, a novel DNA repair protein, promotes tumorigenesis in human esophageal carcinoma. , 2014, International journal of clinical and experimental pathology.

[21]  R. Tawk,et al.  Differences in Colorectal Cancer Outcomes by Race and Insurance , 2015, International journal of environmental research and public health.

[22]  Yi Xing,et al.  Exon arrays provide accurate assessments of gene expression , 2007, Genome Biology.

[23]  Li-xiang Xue,et al.  Genetic alteration and misexpression of Polycomb group genes in hepatocellular carcinoma. , 2015, American journal of cancer research.

[24]  S. Scala,et al.  Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy , 2016, Oncology.

[25]  D. Nicolás-Pérez,et al.  Colorectal cancer screening in the familial risk population: Is colonoscopy still the strategy of choice? , 2016, Gastroenterologia y hepatologia.

[26]  J. Dou,et al.  Advances and perspectives of colorectal cancer stem cell vaccine. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  Heather J. Lee,et al.  ELF5 isoform expression is tissue-specific and significantly altered in cancer , 2016, Breast Cancer Research.

[28]  J. Gustafsson,et al.  Estrogen receptor beta as target for colorectal cancer prevention. , 2016, Cancer letters.

[29]  Changwei Lin,et al.  DNA methylation is involved in the aberrant expression of miR-133b in colorectal cancer cells. , 2015, Oncology letters.

[30]  E. A. Fry,et al.  Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer , 2015, Genetics & epigenetics.

[31]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[32]  Qi Liu,et al.  Gene and isoform expression signatures associated with tumor stage in kidney renal clear cell carcinoma , 2013, BMC Systems Biology.

[33]  E. Itoi,et al.  Skeletal muscle metastases of carcinoma: a clinicopathological study of 12 cases. , 2004, Japanese journal of clinical oncology.

[34]  Ning Leng,et al.  EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments , 2013, Bioinform..

[35]  F. Bazzoli,et al.  Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention , 2013, International journal of molecular sciences.

[36]  Wenmei Li,et al.  Decreased expression of Rab27A and Rab27B correlates with metastasis and poor prognosis in colorectal cancer. , 2015, Discovery medicine.